European Pharma Finally Becomes a Health Matter
December 01
The Evolving Drug Safety Landscape: Implications for Pharma
01 December
Congress Ups the Pharma Ante for Health Reform
House bill boosts rebates and opens the door to government price negotiations.
FDA Warning Letters Target Illegal Online Pharmacies
Feds targeted 136 Web sites offering foreign or unapproved drugs as part of International Internet Week of Action. But does the FDA campaign ignore a larger crisis endangering consumers?
Life Technologies improves e-commerce infrastructure with the help of Infosys
Client Interview Infosys
Christian Wip, IT Director e-business ? Life Technologies, spoke about the e-commerce success story at the company?
Clinical Trials Find Drug Effective In Increasing Female Desire
Dubbed as the 'female Viagra,' Boehringer Ingelheim's filbanserin represents an unprecedented step forward in treating female sexual dysfunction.
Rising to the Challenge in R&D
Allosteric modulators are an emerging class of orally available small molecule drugs that may have multiple advantages compared to traditional drugs.
A Call for Social Media Guidelines
Nearly 70 pharma execs, new media mavens, and even Joe Q. Public packed last week's FDA social media hearings to plead for some form of guidance on how to handle Tweets, blog comments, and off label discussions online.
Bio-Entrepreneur School Welcomes New Applications
16 November 2009.
standard terms and conditions
Pfizer Quick on the Draw with R&D Location Plans
Following through with its promise to waste no time in merging Wyeth and Pfizer, the pharma giant announced restructuring plans for its global research network.
GSK Donates 50 Million H1N1 Doses To WHO
Developing countries will receive the scarce vaccine for free, as GSK remains confident it will fulfill contractual vaccine obligations around the world.
Applying FDA Regulations to Online Marketing - Klick Whitepaper
J&J Cuts Staff in Major Restructuring Move
Johnson & Johnson announced a massive restructuring plan on Tuesday in an effort to save $1.4 billion to $1.7 billion by 2011. The human cost: 7 percent of its workforce.
Glaxo Vies for a Second Act in HIV
A novel joint venture between Glaxo and Pfizer is big on promise. But the combined portfolio and pipeline of HIV drugs? Not so much.
Novo Nordisk Reports 30% Increased Operating Profit
02 November
The Incredible Shrinking Margin?
Emerging country markets are the new black in great expectations for pharma.
The Healthcare Thicket
Despite its success as a proponent of reform, the drug industry, whose main offering is a product easily siloed against other health services, remains vulnerable.
Sanofi Warned for Misleading Tent Card
Sure, prescription information for Sanofi-Aventis's Uroxatral appears on the back of the tent card, but how can consumer?s see it if it's mounted to a pharmacy wall?
10,000 UK Cancer Deaths Could be Avoided
28 October
Bill Campbell
bill Campbell
GAO Accuses FDA of Tardy Trial Data
The US oversight arm scripted a hefty report complaining that FDA is not moving fast enough when it comes to screening clinical trials data for drugs green lit through its expedited approval program.
CROs United
US-based CRO, Health Decisions, hopes to raise the efficacy standards for complex studies and help companies get products to market faster by establishing an international network of CROs.
Pfizer Profits Spike as Wyeth Deal is Finalized
The third quarter reports are in, and Pfizer's profits are up but sales are down. The company is compensating for looming patent expirations with layoffs and restructuring; is it enough to boost sales?
UK's NICE Rejects GSK Breast Cancer Treatment
21 October
What's the best managed pharma company? Find out in the Industry Audit and Company of the Year Podcast
Industry Audit and Company of The year.
Cegedim Talks CRM
Cegedim CEO Laurent Labrune talks to Pharm Exec Europe about how the company is maintaining its CRM lead in a rapidly changing industry.
